Wound Care Innovations, LLC (WCI) was formed with the sole purpose of introducing and distributing a truly unique and innovative solution to the greater than $2.5 billion domestic US wound care market - CellerateRX ™. WCI is the exclusive distributor of a line of Activated Collagen ™ wound care products featuring a patented molecular form of collagen called CellerateRX ™. The Company’s immediate market is with primary buyers including healthcare providers (physicians, clinics, hospitals, homecare, long term care and DME), and a vast secondary consumer market. WCI’s line of Activated Collagen-based products are all FDA cleared as medical devices and have been cleared for use in the management of chronic & acute wounds and skin ulcers.

Product Manufacturing

The Type I hydrolyzed collagen found in CellerateRx ™ comes from a proprietary bovine source and is processed into usable form at an FDA certified lab in Pennsylvania.

WCI procures its product, in finished form, from the manufacturer, The Hymed Group Corporation, our supplier and holder of the patent for the molecular form of our collagen. This product is cleared by the FDA as a medical device.

Design by TSDG